grant · US

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

National Institutes of Health

AT A GLANCE

About this opportunity

National Institutes of Health lists this grant. The listed closing date is 5 Apr 2029. Check the official listing for details.

Who it’s for

Small businesses. Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to…

Explore related listings

General information only, not advice. Govlark lists public opportunities that look relevant to the description given; it does not assess eligibility and does not say you qualify. Always read the official listing and guidelines before applying.

Source: US Government work (public domain) · Source: Grants.gov · Report an error